Canada Pension Plan Investment Board Revance Therapeutics, Inc. Transaction History

Canada Pension Plan Investment Board

  • $98.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$11.47 - $25.07 $88,319 - $193,039
7,700 New
7,700 $88,000
Q1 2023

May 12, 2023
BUY
$18.36 - $35.27 $3.08 Million - $5.91 Million
167,568 New
167,568 $5.4 Million
Q3 2018

Nov 09, 2018
SELL
$23.55 - $30.1 $13.7 Million - $17.5 Million
-582,900 Closed
0 $0
Q1 2017

Jan 31, 2018
BUY
N/A
582,900
582,900 $12.1 Million

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email